<DOC>
	<DOCNO>NCT01990079</DOCNO>
	<brief_summary>The primary goal study evaluate use new smart phone application prevent relapse smoking among people PTSD . The technology intervention combine mobile system reward non-smoking , smoke cessation counseling , smoke cessation medication , use smart phone app . The primary aim evaluate effective intervention prevent smoke relapse compare another intervention include app .</brief_summary>
	<brief_title>Use Technological Advances Prevent Smoking Relapse Among Smokers With PTSD</brief_title>
	<detailed_description>The primary goal current study evaluate use new smart phone application ( app ; Stay Quit Coach ) prevent relapse smoking among individual PTSD . The enhanced technology intervention combine mobile contingency management ( mCM ) , guideline-based smoking cessation counseling , bupropion nicotine replacement therapy ( NRT ) , use Stay Quit Coach . For study , propose clinical trial two-group design 20 smoker PTSD randomize either : QUIT4EVER , intervention combine guideline-based smoke cessation counseling , bupropion NRT , mCM Stay Quit Coach . COMBINED CONTACT CONTROL ( CCC ) intervention identical QUIT4EVER except Stay Quit Coach include . The CCC control compensation , monitoring , time attention effect . Specific aim : AIM 1 : evaluate efficacy QUIT4EVER rate abstinence cigarette ( assessed multiple measure include bioverified abstinence ) short long term abstinence ( measure 3 6 month ) . Hypothesis 1 : QUIT4EVER associate increase long term abstinence ( self-reported bio-verified prolonged abstinence 3 6 month follow-up ) . AIM 2 : assess impact QUIT4EVER counseling treatment completion medication adherence . Hypothesis 2 . Increased abstinence associate QUIT4EVER partially mediate increase telephone counseling treatment completion great medication adherence . AIM 3 : calculate relative cost-effectiveness QUIT4EVER intervention quality adjust life year ( QALY ) . Hypothesis 3 : QUIT4EVER base treatment result great cost-effectiveness compare control condition measure incremental cost-effectiveness ratio . Overall , result study could lead highly efficient , effective , easily disseminate treatment method reduce smoking among smoker PTSD psychiatric disorder .</detailed_description>
	<mesh_term>Nicotine</mesh_term>
	<mesh_term>Bupropion</mesh_term>
	<criteria>1 . Meets criteria current PTSD ; 2 . Has current smoking status least 10 cigarette per day ( verified breath carbon monoxide measurement ) ; 3 . Has smoke least 1 year ; 4 . Is age 18 70 ; 5 . Can speak write current fluent conversation English ; 6 . Is willing make smoking cessation attempt . 1 . Is pregnant ; 2 . Has diagnosis , base DSMIV criterion , schizophrenia , schizophreniform disorder , schizoaffective disorder , current psychotic symptom , delusional disorder , current ( remission ) substance use disorder , and/or current manic episode ; 3 . Will stable medication study period ; 4 . Has history myocardial infarction past 6 month ; 5 . Uses form nicotine cigar , pipe , chew tobacco unwillingness stop use study period ; 6 . Is currently imprison . 7 . Note : Participants may exclude ask refrain take certain study medication seizure disorder , uncontrolled diabetes , eat disorder , current past cirrhosis hepatitis .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>September 2015</verification_date>
	<keyword>PTSD</keyword>
	<keyword>smoking</keyword>
</DOC>